BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16580422)

  • 1. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability and heart rate recovery in patients with coronary artery ectasia.
    Turker Y; Ozaydin M; Yucel H
    Coron Artery Dis; 2010 Jan; 21(1):8-12. PubMed ID: 19838109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
    Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A
    Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
    Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bariatric surgery--induced weight loss on heart rate variability.
    Nault I; Nadreau E; Paquet C; Brassard P; Marceau P; Marceau S; Biron S; Hould F; Lebel S; Richard D; Poirier P
    Metabolism; 2007 Oct; 56(10):1425-30. PubMed ID: 17884456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
    Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy.
    Pagkalos M; Koutlianos N; Kouidi E; Pagkalos E; Mandroukas K; Deligiannis A
    Br J Sports Med; 2008 Jan; 42(1):47-54. PubMed ID: 17526623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
    Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R; Solenghi M; Volpe L; Purcaro A
    Eur Heart J; 2007 May; 28(9):1102-8. PubMed ID: 17456483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metoprolol on heart rate variability in symptomatic patients with mitral valve prolapse.
    Taçoy G; Balcioğlu AS; Arslan U; Durakoğlugil E; Erdem G; Ozdemir M; Cengel A
    Am J Cardiol; 2007 Jun; 99(11):1568-70. PubMed ID: 17531582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow.
    Pekdemir H; Cicek D; Camsari A; Akkus MN; Cin VG; Doven O; Parmaksiz HT; Katircibasi MT; Ozcan IT
    Ann Noninvasive Electrocardiol; 2004 Jan; 9(1):24-33. PubMed ID: 14731213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
    J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.